You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.

Our People

Board of Directors:

  • Mr Mark Grey, Chairman
  • Professor Philip Penfold, Director
  • Mr Stephen Davidson, Director
  • Peter Abrahamson, Managing Director
Mark is an eye care industry opinion leader and was the former Chief Executive of the Queensland Eye Hospital and Chairman of VPSC, Melbourne's private Eye & Ear Hospital. He was also a Director of the Australian Day Hospitals' Association representing ophthalmic surgical facilities.

He was Chairman of IR Law group, Livingstones, from 2010 to 2015, Chairman of Verifact, risk mitigation group from 2008 to 2013 and Director of international finance and accounting group, CPA Australia from 2007 to 2014.

He serves on the board of the Asia Logistics Council in Kuala Lumpur, Malaysia and has been a delegate to the B20 Business Advisory Board to the G20 leadership, in Turkey 2014, China 2016 and Germany 2017.

He has a strong governance, international marketing and strategy planning background and is currently Chairman of A V Technology and Chairman of IT medical group, Scan Care.
is the Chief Scientist and Founder of Eye Co Pty Ltd. He is Editor/Author of the international textbook: "Macular Degeneration" published by Springer. Professor Penfold led the scientific team at Regenera Ltd/Advanced Ocular Systems from start up, to oversubscribed IPO on the ASX, on to transactions with Alcon, QLT and others. His initial invention and patent suite, including the Triamcinolone ocular injection method, was licensed by Alcon in a high value transaction in 2005, and products he developed are now on global markets with proper regulatory approvals, including from USFDA. He invented Vista+™ MC, now protected by granted patents throughout Europe. Professor Penfold has held senior academic positions at Sydney University and at Australian National University and is currently an adjunct professor at ANU's John Curtin School of Medical Research.
is Eye Co's, Company Secretary and Chief Financial Officer, and has previously been involved in managing the financial affairs of the company. Mr. Mr Davidson is a CPA with over 35 years' experience in corporate and NFP accounting and management, including as an accountant with Novartis group companies. Most recently he has been CFO and now Corporate Service Manager for the Australian Chamber Orchestra and now consults to the performing arts industry on corporate governance, systems, finance and administration. He was also involved in the successful, oversubscribed IPO, and subsequent licensing deals of Regenera Ltd and its Retmed research subsidiary. Mr Davidson has been a shareholder since Eye Co's founding, and was appointed to the Board in March of 2013.
Is a senior executive with more than 20 years' experience as CEO, and Managing Director of an ASX listed company and of major subsidiaries of the ophthalmic companies Allergan and Advanced Medical Optics. Operated in Australia, New Zealand and in several Asian markets based in Hong Kong and Shanghai. Has proven skills in the pharmaceutical, medical device, FMCG and OTC sectors with demonstrated effectiveness in leadership, strategic planning, and transformational change.